Osteoporosis drug may strengthen bones beyond density, new study hints

This study looks at how teriparatide, a bone-building drug for severe osteoporosis, affects bone structure in postmenopausal women. Researchers will use a special scanner to see changes in bone thickness and tiny connecting rods at the wrist and ankle over 24 months. The goal is to understand if the drug improves bone quality beyond just mineral density, which could help predict fracture risk better. Sixty women with a history of fractures or very low bone density are enrolled.